美敦力公佈財年第一季度營收98億美元,調整後每股收益為$1.45;按報告口徑和有機口徑計算,營收均增長13.7%。美敦力有機銷售額增長13.7%,較業績指引中值高出約200個基點;心血管和醫療外科業務銷售額均超出預期。美敦力及其糖尿病業務分拆公司Minimed上調全年業績指引,推動兩隻股票走高。來源Medtronic's Diabetes Spinoff Just Surged. What To Look For In Its Earnings.Investor's Business DailyMedtronic's Diabetes Spinoff Just Surged. What To Look For In Its Earnings.Yahoo Finance